18亿美元！法国工业软件巨头，收购了一家AI临床！
Merged summary
TL;DR - Dassault Systèmes will acquire AI-native life-sciences compliance platform ArisGlobal for $1.8 billion in cash, plus up to $200 million tied to AI revenue milestones. The deal expands Dassault’s clinical and regulatory software capabilities across the therapeutic lifecycle.
- ArisGlobal’s NavaX AI automates patient-safety, regulatory, medical-affairs, and quality workflows in highly regulated environments.
- The platform reportedly delivers productivity gains exceeding 30% and processes over 12 million patient-safety reports annually.
- ArisGlobal serves more than 200 organizations, including half of the world’s top 50 biopharmaceutical companies.
- Dassault plans to combine ArisGlobal’s regulated operations and real-world evidence capabilities with its discovery, clinical-trial, manufacturing, and quality expertise.
Sources (1)
18亿美元！法国工业软件巨头，收购了一家AI临床！
TL;DR - Dassault Systèmes will acquire AI-native life-sciences compliance platform ArisGlobal for $1.8 billion in cash, plus up to $200 million tied to AI revenue milestones. The deal expands Dassault’s clinical and regulatory software capabilities across the therapeutic lifecycle.
- ArisGlobal’s NavaX AI automates patient-safety, regulatory, medical-affairs, and quality workflows in highly regulated environments.
- The platform reportedly delivers productivity gains exceeding 30% and processes over 12 million patient-safety reports annually.
- ArisGlobal serves more than 200 organizations, including half of the world’s top 50 biopharmaceutical companies.
- Dassault plans to combine ArisGlobal’s regulated operations and real-world evidence capabilities with its discovery, clinical-trial, manufacturing, and quality expertise.